Altria Group (MO) vs Trulieve Cannabis Subordinate Voting Shares (TRLV)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Trulieve Cannabis Subordinate Voting Shares (TRLV) has outperformed Altria Group (MO) over the past year, gaining 21.3% versus a gain of 4.1%. Over five years, MO leads with a +42.5% price change compared with -58.9% for TRLV. Altria Group is the larger company by market cap ($115.85 billion vs $2.08 billion), about 55.8 times the size.
On valuation, Altria Group trades at a lower forward P/E (11.8x vs 19.4x for Trulieve Cannabis Subordinate Voting Shares). Altria Group pays a dividend yielding 6.11%, while Trulieve Cannabis Subordinate Voting Shares does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MO | TRLV |
|---|---|---|
| Share price | $69.38 | $10.78 |
| Market cap | $115.85B | $2.08B |
| 1-day change | +1.21% | +1.22% |
| YTD return | +20.33% | +24.05% |
| 1-year return | +4.10% | +21.26% |
| 5-year return | +42.46% | -58.89% |
| P/E ratio (TTM) | 14.42 | — |
| Forward P/E | 11.83 | 19.37 |
| EPS (TTM) | $4.81 | $-2.46 |
| Dividend yield | 6.11% | 0.00% |
| Annual dividend | $4.24 | $0.00 |
| Revenue (latest FY) | $23.28B | — |
| Revenue growth (YoY) | -3.08% | — |
| Net income (latest FY) | $6.95B | — |
| Gross margin | 62.47% | — |
| Operating margin | 42.52% | — |
| Net margin | 29.84% | — |
| 52-week high | $77.06 | $13.28 |
| 52-week low | $54.70 | $4.62 |
| Distance from 52-week high | -9.97% | -18.83% |
| Analyst consensus | hold | strong_buy |
| Avg. price target upside | +0.89% | +68.65% |
| Average volume | 8.50M | 1.60M |
| Shares outstanding | 1.67B | 170.16M |
| Employees | 5,900 | 5,000 |
| Sector | Health Care | Health Care |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Altria Group is about 55.8 times larger than Trulieve Cannabis Subordinate Voting Shares by market value ($115.85B vs $2.08B).
- TRLV has outperformed MO by 17.2 percentage points over the past year.
- Altria Group offers a meaningfully higher dividend yield (6.11% vs 0.00%).
About Altria Group
MO stock →Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. It offers cigarettes primarily under the Marlboro brand; large cigars and pipe tobacco under the Black & Mild brand; moist smokeless tobacco and oral tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands; oral nicotine pouches under the on! brand; and e-vapor products under the NJOY ACE brand.
Health Care · Medicinal Chemicals and Botanical Products · 5,900 employees
About Trulieve Cannabis Subordinate Voting Shares
TRLV stock →Trulieve Cannabis Corp. operates as a cannabis retailer in the United States.
Health Care · Medicinal Chemicals and Botanical Products · 5,000 employees
MO vs TRLV FAQ
Which is bigger, Altria Group or Trulieve Cannabis Subordinate Voting Shares?
Altria Group (MO) is larger, with a market capitalization of $115.85B compared with $2.08B for Trulieve Cannabis Subordinate Voting Shares (TRLV).
Which stock has performed better over the past year, MO or TRLV?
TRLV returned +21.26% over the past 12 months, compared with +4.10% for MO (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Altria Group or Trulieve Cannabis Subordinate Voting Shares?
Altria Group pays a dividend yielding 6.11%, while Trulieve Cannabis Subordinate Voting Shares does not currently pay a regular dividend.
Are Altria Group and Trulieve Cannabis Subordinate Voting Shares in the same industry?
Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.